Skip to content

Evaluation of the treatment of dentin sensitivity with diode laser and prophylactic desensitizing paste

Evaluation of the use of Calcium and Sodium Phosphosilicate prophylactic paste and Diode Laser in the treatment of dentin hypersensitivity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3qb993t
Enrollment
30
Registered
2024-10-04
Start date
2024-11-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin sensitivity Stomatognathic Diseases

Interventions

This is a randomized, controlled, split-mouth, double-blind clinical trial. A total of 30 permanent teeth with dentin hypersensitivity from young individuals of both genders who meet the eligibility c

Sponsors

Faculdade de Odontologia da Universidade Federal de Goiás
Lead Sponsor
Faculdade de Odontologia da Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Individuals meeting the following criteria will be included in the study: individuals of both sexes; aged between 18 and 40 years; presence of at least two teeth with non-carious cervical lesions and/or gingival recessions associated with symptoms of dentin hypersensitivity; presence of at least one hypersensitive tooth on each side of the dental arch, non-adjacent to each other; pain response equal to or greater than 4 on the Visual Analog Scale (VAS) following tactile stimulation; sensitivity response to air-blast stimulus corresponding to score 1 on the Schiff Cold Air Sensitivity Scale (SS); good general health status; and absence of known allergies to the products to be tested

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following criteria will be excluded from the study: pregnant or breastfeeding women; continuous use or use within the previous six months of analgesics, psychotropic drugs, or anti-inflammatory medications; heavy smoking; presence of eating disorders or systemic conditions associated with chronic acid regurgitation; excessive dietary or environmental exposure to acidic agents; presence of oral pathologies capable of causing pain similar to dentin hypersensitivity; advanced periodontal disease; history of periodontal surgery, orthodontic treatment, desensitizing treatment, or dental bleaching within the previous 90 days; teeth presenting cracks or coronal fractures; teeth restored within the previous three months; extensively restored teeth and/or teeth with restorations extending to the experimental area; and teeth with fixed prostheses or serving as abutments for fixed or removable prostheses

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical reduction of dentin hypersensitivity, verified using the Visual Analog Scale (VAS) and the Schiff Cold Air Sensitivity Scale (SS), with a reduction in sensitivity scores compared with baseline values and statistically significant differences between evaluation periods being observed;To evaluate the comparative efficacy of the two interventions for the treatment of dentin hypersensitivity, verified through comparison of scores obtained using the Visual Analog Scale (VAS) and the Schiff Cold Air Sensitivity Scale (SS), with statistically significant differences between the tested protocols being observed

Secondary

MeasureTime frame
To observe the duration of the therapeutic effects of the interventions, verified through longitudinal analysis of scores obtained using the Visual Analog Scale (VAS) and the Schiff Cold Air Sensitivity Scale (SS), with maintenance of sensitivity reduction throughout the follow-up periods being observed;To evaluate the impact of dentin hypersensitivity reduction on participants’ daily quality of life, verified using the Dentine Hypersensitivity Experience Questionnaire (DHEQ-15), with statistically significant improvement in scores related to functional and dietary discomfort after the interventions being observed

Countries

BR

Contacts

Public ContactSara Maria Melo

Univerdade Federal de Goiás

melosara556@gmail.com+55(62)994872515

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 11, 2026